SUSAN WANG: Open Payments
NPI 1437301488 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 14 payments from 9 companies in 2025. Trend: 2023 $245 · 2024 $403 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $243 |
| Novo Nordisk Inc | 2 | $241 |
| LEO Pharma Inc. | 2 | $156 |
| Travere Therapeutics, Inc. | 1 | $130 |
| AstraZeneca Pharmaceuticals LP | 2 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| Galderma Laboratories, L.P. | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
Products named: Wegovy, VTAMA, ANZUPGO, Filspari, LOKELMA, JARDIANCE, NEMLUVIO, ADBRY.
Industry payments across CA — which companies pay providers there.
